<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7765155/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Biological activities of rosmarinic acid (RA) (modified from Bulgakov et al. [ 
   <a rid="B81-antioxidants-09-01273" ref-type="bibr">81</a>]). 
  </p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Biological Activity</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Potential Usage</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant activity and membrane stabilization 
    <sup>a</sup>
   </td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Protection against chemically induced chromosome breakage and primary DNA damage</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase of the physical and oxidative stability of liposomes 
    <sup>a</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction of the frequency of micronuclei and the extent of DNA damage induced by doxorubicin 
    <sup>a</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppression of UVB-induced alterations to human keratinocytes 
    <sup>a</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin protection against UVB light</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction of IFN-γ and IL-4 production by activated T cells 
    <sup>b</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin protection against atopic dermatitis</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protection of neurons against insults 
    <sup>a</sup>
   </td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Rosmarinic acid is a promising neuroprotective compound of potential use at the nutritional/pharmaceutical interface</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cognitive-enhancing effect 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention of the development of Alzheimer’s disease 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Attenuation of the degeneration of motor neurons and extension of the life span of model mice 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-angiogenic activity against retinal neovascularization 
    <sup>b</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of retinopathy</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of TNF-α-induced ROS generation and NF-κB activation and activation of TNF-α-induced apoptosis 
    <sup>a</sup>
   </td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Promising for cancer prevention and treatment of a variety of human cancers that are resistant to chemotherapy</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The long-term exposure of animals to RA in the diet is sufficient for cancer chemoprevention 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of bone metastasis from breast carcinomas 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifibrotic activity 
    <sup>a,b</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug candidate for ameliorating liver fibrosis</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dramatic apoptotic activity on potentially pathogenic CD4 
    <sup>+</sup>CD45RO 
    <sup>+</sup> effector T cells 
    <sup>a</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of rheumatoid arthritis</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of caspase-1 activity, mitochondrial apoptotic pathway and activation of NF-κB by cisplatin 
    <sup>a</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention of harmful side effects of anticancer agents in patients undergoing chemotherapy</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>
    <sup>a</sup> in vitro studies; 
    <sup>b</sup> in vivo (animals); 
    <sup>c</sup> in vivo (humans). 
   </p>
  </p>
 </tfoot>
</table>
